A drug commonly used to manage symptoms of Alzheimer disease and other dementias – donepezil – is associated with a two-fold higher risk of hospital admission for rhabdomyolysis, a painful condition of muscle breakdown, compared with several other cholinesterase inhibitors, found a study in CMAJ ( Canadian Medical Association Journal ).
https://www.eurekalert.org/pub_releases/2019-09/ji-cud091019.php